Ireland Reimburses Medical Marijuana-Based Drug For Chemotherapy-Induced Nausea And Vomiting - Jazz Pharmaceuticals (NASDAQ:JAZZ)

Althea Group Holdings Limited (ASX: AGH), an Australian manufacturer of cannabis-based medicines and recreational cannabis products confirmed that Ireland’s Primary Care Reimbursement Service (‘PCRS’) has approved Althea THC20:CBD1 cannabis oil for reimbursement in Ireland. The company’s sub

Related Keywords

United Kingdom ,Ireland ,Australia ,Australian ,Irish ,Michael Berger ,Joshua Fegan ,Benzinga Potprofits ,Access Program ,Gw Pharmaceuticals ,Jazz Pharmaceuticals ,Ireland Citizens Assembly On Drugs ,Health Service Executive ,Ireland Primary Care Reimbursement Service ,Althea Group Holdings ,Care Reimbursement Service ,Group Holdings Limited ,Primary Care Reimbursement Service ,Myaccess Clinics ,Citizens Assembly ,Drugs Use ,Access Clinics ,Access Clinic ,Sativex Aslo Reimbursed ,Managed Access Program ,High Tech Hub ,